Takeda Pharmaceutical Co Ltd (NYSE:TAK)

17.63
Delayed Data
As of Oct 15
 +0.38 / +2.20%
Today’s Change
15.50
Today|||52-Week Range
21.61
+4.82%
Year-to-Date
Big Pharma Has Mad Love For These 2 Biotechs
Oct 11 / MotleyFool.com - Paid Partner Content
Karyopharm Signs $150M Royalty Agreement to Support Xpovio
Sep 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close17.25
Today’s open17.36
Day’s range17.36 - 17.64
Volume1,825,443
Average volume (3 months)1,369,349
Market cap$53.9B
Data as of 6:30pm ET, 10/15/2019

Growth & Valuation

Earnings growth (last year)-52.61%
Earnings growth (this year)-205.40%
Earnings growth (next 5 years)+16.80%
Revenue growth (last year)+18.39%
P/E ratio42,641.9
Price/Sales2.08
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+1.22+0.72%
----
ZTSZoetis Inc+2.12+1.67%
VRTXVertex Pharmaceutica...+2.55+1.47%
Data as of 6:30pm ET, 10/15/2019

Financials

Next reporting dateOctober 31, 2019
EPS forecast (this quarter)-$0.00
Annual revenue (last year)$18.9B
Annual profit (last year)$984.1M
Net profit margin5.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Osaka, Osaka

Forecasts